3-D Matrix, Ltd. (TYO:7777)

Market Cap	70.32B +284.7%
Revenue (ttm)	9.22B +38.4%
Net Income	1.25B
EPS	9.63
Shares Out	124.03M
PE Ratio	58.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,134,000
Average Volume	9,943,965
Open	637.00
Previous Close	717.00
Day's Range	567.00 - 656.00
52-Week Range	102.00 - 793.00
Beta	0.53
RSI	46.77
Earnings Date	Mar 13, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In fiscal year 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.